FDA Product Code OCL: Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue
Under FDA product code OCL, surgical devices that combine cutting, coagulation, and ablation functions are cleared for multi-modal tissue treatment.
These advanced energy platforms integrate multiple energy modalities — such as radiofrequency and microwave — into a single device capable of performing tissue cutting, hemostasis, and ablation in a single instrument. They are used in cardiac surgery and interventional procedures.
OCL devices are Class II medical devices, regulated under 21 CFR 878.4400 and reviewed by the FDA Cardiovascular panel.
Leading manufacturers include AtriCure, Inc., Medtronic, Inc. and Ncontact Surgical, Inc..
54
Total
54
Cleared
105d
Avg days
1997
Since
54 devices
Cleared
Jun 06, 2002
MODIFIED CARDIAC CRYOSURGICAL SYSTEM, MODELS 6TCS1 & 6TCSE
Endocare, Inc.
Cardiovascular
69d
Cleared
Jan 25, 2002
CARDIOBLATE SURGICAL ABLATION PEN, MODEL 60811C
Medtronic Vascular
Cardiovascular
102d
Cleared
Sep 20, 2001
SURGICAL LIGHTSTIC 180, MODEL 180 L, MODEL 180 C
Cardiofocus, Inc.
Cardiovascular
86d
Cleared
Jun 15, 2001
CRYOCARE CARDIAC SURGICAL SYSTEM
Endocare, Inc.
Cardiovascular
71d
Cleared
Feb 03, 1998
CRYOGEN CARDIAC CRYOSURGICAL SYSTEM
Cryogen, Inc.
Cardiovascular
78d
Cleared
May 09, 1997
HEARTPORT MAZE SYSTEM: CRYOPROBE SET
Heartport, Inc.
Cardiovascular
88d